SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.43-0.7%Feb 6 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary D Zehr who wrote (448)1/7/1997 8:12:00 PM
From: Henry Niman   of 32384
 
Gary, I picked up the Reuter's headlines. LGND (through ALRIZ) put
out two formal press releases. I believe the Reuter's story was done
by a reporter at the conference who was taking notes. I think that
LGND puts that info into a "rumor" rather than "news" story. The
leptin deal will become news when the agreement is signed. I think
the "big boys' love this kind of info and expect them to line up at
the buy window. I epxect LGND to put out a formal press release, but
investors will do better if they buy BEFORE the news. I am not surprised
at the diabetes deal. I had reported this earlier, and now the ALRT268
data looks even stronger than the Targretin data, so I think the
Targretin phase II trial will go quickly, and the ALRT268 compound will be
kept in reserve (because it still has to go through Phase I which
probably won't start until next year). Most of the recent rally has been
retail. The big boys would love to see a dip so they can hop on board,
but the smart money will be buying instead of taking profits at these levels
because it should be rather clear that the good news will continue
to come out (in formal press releases).

Henry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext